Comparative efficacy and safety of immunomodulatory therapies for sepsis: a systematic review and network meta-analysis - Scorecard - MDSpire

Comparative efficacy and safety of immunomodulatory therapies for sepsis: a systematic review and network meta-analysis

  • By

  • Rong Luo

  • Shunyao Xu

  • Yuting Chen

  • Zhenmi Liu

  • Xiaofan Deng

  • Chenxi Li

  • Kangping Hui

  • Youlian Chen

  • Chengying Hong

  • ChunBo Chen

  • Huaisheng Chen

  • May 12, 2026

  • 0 min

Share

Clinical Scorecard: Efficacy and Safety Comparison of Immunomodulatory Treatments for Sepsis: A Systematic Review and Network Meta-Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsDysregulated immune response characterized by hyper-inflammatory and immune suppression phases, as detailed in the source.
Target Population
Care Setting

Key Highlights

  • additional_highlight

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • I
      • n
      • c
      • l
      • u
      • d
      • e
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • b
      • i
      • o
      • m
      • a
      • r
      • k
      • e
      • r
      • s
      • o
      • r
      • c
      • l
      • i
      • n
      • i
      • c
      • a
      • l
      • s
      • i
      • g
      • n
      • s
      • f
      • o
      • r
      • m
      • o
      • n
      • i
      • t
      • o
      • r
      • i
      • n
      • g
      • a
      • s
      • m
      • e
      • n
      • t
      • i
      • o
      • n
      • e
      • d
      • i
      • n
      • t
      • h
      • e
      • s
      • o
      • u
      • r
      • c
      • e
      • .

      Risks

        Patient & Prescribing Data

        Add specific outcomes or metrics to support the insights provided.

        Clinical Best Practices

        • additional_practice

        Related Resources & Content

        Original Source(s)

        Comparative efficacy and safety of immunomodulatory therapies for sepsis: a systematic review and network meta-analysis

        • by Rong Luo, Shunyao Xu, Yuting Chen, Zhenmi Liu, Xiaofan Deng, Chenxi Li, Kangping Hui, Youlian Chen, Chengying Hong, ChunBo Chen, Huaisheng Chen

        • May 12, 2026

        Related Content

        Beyond demographic tables: integrating data quality in clinical trial representativeness

        Compliance of procalcitonin-guided antibiotic therapy in adult infectious patients in China: a multicenter real-world retrospective study

        Hydrocortisone May Lower Severe CAP Mortality

        Network meta-analysis suggests hydrocortisone may offer mortality and ventilation benefits, although evidence certainty remained low.